US pharma co denied patent on hepatitis C combo therapy

NEW DELHI: The Indian Patent Office has refused to grant a patent to US pharmaceutical firm AbbVie on its Hepatitis C combination therapy glecaprevir/pibrentasvir, marketed globally as Mavyret. The combination therapy is considered a key treatment for Hepatitis C, and the availability of affordable generic versions remains critical for widening patient access. “The order demonstrates…

Read More

CBI arrests coaching centre founder

PUNE/NEW DELHI: CBI arrested Shivraj Raghunath Motegaonkar, the director of Maharashtra-based Renukai Career Centre (RCC), alleging he circulated leaked NEETUG 2026 questions through coaching networks and “mock tests” conducted before examination, report Gitesh Shelke, Rajshekhar Jha & Koushiki Saha. This is the 10th arrest by CBI, which has now widened its probe, bringing more than…

Read More